Effect of alogliptin on endothelial dysfunction induced by hyperlipidemia

Effect of alogliptin on endothelial dysfunction induced by hyperlipidemia - Effect of alogliptin on endothelial dysfunction induced by hyperlipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008297

Enrollment

Registered

2012-12-01

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haelthy subjects patients wiht coronary artery disease subjects wiht metabolic symdrome

Interventions

alogliptin P.O. placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy subjects patients with coronary artery disease patietns with metabolic syndrome

Exclusion criteria

Exclusion criteria: patients with hemodyalysis

Design outcomes

Primary

Measure	Time frame
postprandial lipemia postprandiel endothelial function	—

Countries

Japan

Contacts

Public ContactToru Miyoshi

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Cardiovascular Medicine

086-235-7351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026